Robert D. Hardie serves as Executive at Acumen Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert D. Hardie has executed 6 insider transactions totaling $17.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 6, 2021 involved exercising options for 2,076,326 shares valued at $0.
Robert D. Hardie currently holds 3,201,156 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert D. Hardie has been a net buyer of ABOS stock. They have purchased $17.0M and sold $0 worth of shares.
Robert D. Hardie's most recent insider trade was on Jul 6, 2021, when they sold 2,076,326 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $16.00 |
| Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 1,124,830 | $N/A | Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 657,985 | $N/A | Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 2,950,484 | $N/A | Discretionary |
| Jul 6, 2021 | ABOS | $5.0M | Purchase | 312,500 | $16.00 | Discretionary |